RxDoctor Payments Data

David Schoenfeld, MD

Dermatology · Carrollton, GANPI 1184622946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 460 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.

$9,575in general payments, 2019–2025

Across 460 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$1K
  • Novartis$1K
  • UCB, Inc.$816
  • Johnson & Johnson$623
  • Sun Pharmaceutical Industries Inc.$597
  • plus $4K from 22 others
$4,203in research payments, 2019–2025

Across 4 payments — averaging $1050.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$4K

What the payments were for

  • Food & beverage$9,49499%
  • Education$811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,575 in reported general payments places this provider in the 75th percentile of 345 dermatology providers in Georgia.

See all dermatology providers in Georgia

Medicare billing

Part B allowed, 2024
$274,399
Medicare patients
779
Services billed
4,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab14$100,364
Triamcinolone Acetonide243$3,249
Ketoconazole113$2,667
Betamethasone Valerate39$1,672
Hydrocortisone106$1,653
Clindamycin Phosphate31$1,305
Clobetasol Propionate40$1,180
Fluocinonide24$1,084
ValacyclovirValacyclovir Hcl49$834
Betamethasone Dipropionate20$808
Doxycycline Hyclate30$271
CiclopiroxCiclopirox Olamine11$231
Minocycline Hcl13$226
Mupirocin30$161
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$128

Paid to pharmacies, not to this prescriber.

Other dermatology in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →